🕵️ Nasus Pharma Ltd ($NSRX)

SEC insider & ownership activity, last 12 months · CIK 2029039 · every row links its SEC filing

Over the last 12 months insiders bought $62K with no open-market selling against it. Teleman Dan Benjamin bought $62K in discretionary trades (Mar–Jun). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net +$31K Mar 2026: net +$31K Apr 2026: net +$11K May 2026: net +$0 Jun 2026: net +$20K Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

1 buyer, $62K (3 lots) · 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Teleman Dan Benjamin3$62K 0Jun 17, 2026

5%+ holders

HolderStakeClassScheduleEvent
Udi Gilboa 21.1% 13GNov 10, 2025 filing ↗
Dr. Dalia Megiddo 20.9% 13GNov 12, 2025 filing ↗
Dr. Ronnie Hershman 15.3% 13GNov 13, 2025 filing ↗
Balyasny Asset Management L.P. 10.0% 13GMay 15, 2026 filing ↗
BAM GP LLC 10.0% 13GMay 15, 2026 filing ↗
Balyasny Asset Management Holdings LP 10.0% 13GMay 15, 2026 filing ↗
Dames GP LLC 10.0% 13GMay 15, 2026 filing ↗
Dmitry Balyasny 10.0% 13GMay 15, 2026 filing ↗
Hershman Holdings LLC 9.9% 13GNov 13, 2025 filing ↗
Capital Point Ltd. 6.3% 13GAug 20, 2025 filing ↗
Funicular Funds, LP 5.2% 13GApr 7, 2026 filing ↗
Cable CAR Capital, LP 5.2% 13GApr 7, 2026 filing ↗
Ma-Weaver Jacob 5.2% 13GApr 7, 2026 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

No 8-K filings in the last 12 months.